Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Alimentary Pharmacology and Therapeutics

• Publication date

  2006-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1365-2036.2006.03067.xPMID 16961752
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial

  2005cited by this paper
• A randomized placebo-controlled clinical trial of probiotics (l. Jonhsonii, La1 (R)) on early encloscopic recurrence of Crohn's disease (CD) after ileo-caecal resection

  2005cited by this paper
• Human defensins in Crohn's disease.

  2005cited by this paper
• Selective probiotic bacteria induce IL-10-producing regulatory T cells in vitro by modulating dendritic cell function through dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin.

  2005cited by this paper
• Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing

  2005cited by this paper
• Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract

  2005cited by this paper
• Association Between Toll‐like Receptor 4 and Inflammatory Bowel Disease

  2005cited by this paper
• Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.

  2005cited by this paper
• Spatial Organization and Composition of the Mucosal Flora in Patients with Inflammatory Bowel Disease

  2005cited by this paper
• Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine

  2004cited by this paper
• High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

  2004cited by this paper
• Modulation of human dendritic cell phenotype and function by probiotic bacteria

  2004cited by this paper
• Bacterial Probiotic Modulation of Dendritic Cells

  2004cited by this paper
• Prebiotic carbohydrates modify the mucosa associated microflora of the human large bowel

  2004cited by this paper
• Campylobacter jejuni Binds Intestinal H(O) Antigen (Fucα1, 2Galβ1, 4GlcNAc), and Fucosyloligosaccharides of Human Milk Inhibit Its Binding and Infection*

  2003cited by this paper
• Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis

  2003cited by this paper
• Inducible and Constitutive &bgr;-Defensins Are Differentially Expressed in Crohn's Disease and Ulcerative Colitis

  2003cited by this paper
• Control of inflammatory diseases by pathogens: lipids and the immune system

  2003cited by this paper
• Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG

  2002cited by this paper
• Prebiotic effects of inulin and oligofructose

  2002cited by this paper
• Butyrate Inhibits NF-κB Activation in Lamina Propria Macrophages of Patients with Ulcerative Colitis

  2002cited by this paper
• Effect of Dietary Inulin Supplementation on Inflammation of Pouch Mucosa in Patients With an Ileal Pouch-Anal Anastomosis

  2002cited by this paper
• Oligofructose and long-chain inulin: influence on the gut microbial ecology of rats associated with a human faecal flora

  2001cited by this paper
• Molecular analysis of commensal host-microbial relationships in the intestine.

  2001cited by this paper
• Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods.

  2000cited by this paper
• Anti‐inflammatory effects of sodium butyrate on human monocytes: potent inhibition of IL‐12 and up‐regulation of IL‐10 production

  2000cited by this paper
• The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis

  2000cited by this paper
• Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease.

  2000cited by this paper
• Topical butyrate for acute radiation proctitis: randomised, crossover trial.

  2000cited by this paper
• Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.

  2000cited by this paper
• Combined Oral Sodium Butyrate and Mesalazine Treatment Compared to Oral Mesalazine Alone in Ulcerative Colitis

  2000cited by this paper
• The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line.

  2000cited by this paper
• Prophylaxis of pouchitis onset with probiotic therapy: A double‐blind, placebo‐controlled trial

  2000cited by this paper
• Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after cesarean delivery.

  1999cited by this paper
• Postoperative recurrence of Crohn's disease: pathophysiology and prevention.

  1999cited by this paper
• Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial.

  1999cited by this paper
• Quality of life in inflammatory bowel disease: background and definitions.

  1999cited by this paper
• Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis

  1999cited by this paper
• Wheat bran affects the site of fermentation of resistant starch and luminal indexes related to colon cancer risk: a study in pigs

  1999cited by this paper
• Functional food properties of non-digestible oligosaccharides: a consensus report from the ENDO project (DGXII AIRII-CT94-1095)

  1999cited by this paper
• Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

  1999cited by this paper
• In vivo colonic butyrate metabolism and colonic permeability in extensive ulcerative colitis.

  1998cited by this paper
• In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis.

  1998cited by this paper
• Functional food science and gastrointestinal physiology and function

  1998cited by this paper
• Ecological control of the gastrointestinal tract. The role of probiotic flora

  1998cited by this paper
• Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics.

  1995cited by this paper
• Acute pouchitis and deficiencies of fuel

  1995cited by this paper
• Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

  1995cited by this paper
• Effects of short chain fatty acids on gut morphology and function.

  1994cited by this paper
• A placebo controlled trial of metronidazole for recurrence prevention of Crohn's disease after resection of the terminal ileum

  1992cited by this paper
• Metabolic and intestinal effects of short-chain fatty acids.

  1990cited by this paper

• Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment

  2023cites this paper
• BENEFÍCIOS DO USO DE PROBIÓTICOS EM PACIENTES SUBMETIDOS A TERAPIA NUTRICIONAL ENTERAL

  2023cites this paper
• Physical Activity as an Adjunct Treatment for People Living with HIV?

  2022cites this paper
• The Beneficial Effect of Coarse Cereals on Chronic Diseases through Regulating Gut Microbiota

  2021cites this paper
• Role of food proteins and bioactive peptides in inflammatory bowel disease

  2019cites this paper
• The Gastrointestinal Disease to the Microbiota Treatment : From the Present to the Future

  2019cites this paper
• Characterization of the Pro-Inflammatory Cytokine IL-1[beta] on Butyrate Metabolism in Colorectal Cancer Cells

  2017cites this paper
• Single fecal microbiota transplantation failed to change intestinal microbiota and had limited effectiveness against ulcerative colitis in Japanese patients

  2017cites this paper
• Diet therapy for inflammatory bowel diseases: The established and the new.

  2016cites this paper
• Uloga medicinske sestre kroz aspekt prehrane u prikazu slučaja Crohnove bolesti

  2016cites this paper
• Efficacy of Symbiotics in an Experimental Model of Endotoxic Shock Induced by Lipopolysaccharide from Escherichia Coli

  2016cites this paper
• Ecophysiology of novel intestinal butyrate-producing bacteria

  2016cites this paper
• Lactobacillus acidophilus counteracts enteropathogenic E. coli-induced inhibition of butyrate uptake in intestinal epithelial cells.

  2015cites this paper
• Can Bacteriotherapy Using Commercially Available Probiotics, Prebiotics, and Organic Acids Ameliorate the Symptoms Associated With Runting-Stunting Syndrome in Broiler Chickens?

  2015cites this paper
• O PAPEL ANTIOXIDANTE DA MESALAZINA NO MODELO EXPERIMENTAL DE COLITE INDUZIDA POR ÁCIDO ACÉTICO EM RATOS

  2015cites this paper
• Fiber in the Treatment and Maintenance of Inflammatory Bowel Disease: A Systematic Review of Randomized Controlled Trials

  2014cites this paper
• Tributyrin supplementation protects mice from acute ethanol-induced gut injury.

  2014cites this paper
• Influência da administração de indometacina e leite fermentado por bactérias láticas sobre o peso de ratos

  2013cites this paper
• Management of Chronic Diarrhea in an Adult Horse

  2013cites this paper
• [Roles of enteric microbial composition and metabolism in health and diseases].

  2013cites this paper
• The role of the gut microbiota in nutrition and health

  2012cites this paper
• Butyrate: implications for intestinal function

  2012cites this paper
• A novel nutrient sensing mechanism underlies substrate-induced regulation of monocarboxylate transporter-1.

  2012cites this paper
• Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

  2011cites this paper
• REVISTA VERDE DE AGROECOLOGIA E DESENVOLVIMENTO SUSTENTÁVEL GRUPO VERDE DE AGRICULTURA ALTERNATIVA (GVAA) ISSN 1981-8203 Revisão de Literatura

  2011cites this paper
• The use of probiotics in gastrointestinal diseases

  2010cites this paper
• Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.

  2010cites this paper
• Sickness behavior induced by endotoxin can be mitigated by the dietary soluble fiber, pectin, through up-regulation of IL-4 and Th2 polarization.

  2010cites this paper
• The role of the gut microbiota in inflammatory diseases of childhood

  2010cites this paper
• UNIVERSIDADE FEDERAL DA PARAÍBA CENTRO DE TECNOLOGIA PROGRAMA DE PÓS-GRADUAÇÃO EM CIÊNCIA E TECNOLOGIA DE ALIMENTOS

  2010influential citation
• Basics of GI Physiology and Mucosal Immunology

  2009cites this paper
• Dietary modulation of peroxisome proliferator-activated receptor gamma

  2008cites this paper
• What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? Probing for answers with stable isotopes.

  2008cites this paper
• The interaction of butyrate with TNF-alpha during differentiation and apoptosis of colon epithelial cells: role of NF-kappaB activation.

  2008cites this paper
• [Intestinal flora, probiotics, prebiotics, symbiotics and novel foods].

  2007cites this paper
• Flora intestinal, probiticos, prebiticos, simbiticos y alimentos novedosos

  2007cites this paper
• Innate and Adaptive Immunity in Childhood Celiac

  2006cites this paper
• Innate and adaptive immunity in childhood celiac disease

  2006cites this paper